Skip to Content

WPI 2234 (Tetracycline 250 mg)

Pill imprint WPI 2234 has been identified as Tetracycline hydrochloride 250 mg.

Tetracycline is used in the treatment of acne; bacterial infection; bladder infection; chlamydia infection; epididymitis, sexually transmitted (and more), and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Tetracycline 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Tetracycline hydrochloride 250 mg WPI 2234
Tetracycline hydrochloride 250 mg WPI 2234
Tetracycline hydrochloride
Imprint:
WPI 2234
Strength:
250 mg
Color:
Orange & Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Tetracyclines
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Watson Pharmaceuticals, Inc.
National Drug Code (NDC):
00591-2234
Inactive Ingredients:
lactose
magnesium stearate
sodium lauryl sulfate
D&C Yellow No. 10
FD&C Yellow No. 6
gelatin
titanium dioxide
benzyl alcohol
butylparaben
D&C Red No. 22
edetate calcium disodium
methylparaben
propylparaben
silicon dioxide
sodium propionate
shellac
ferrosoferric oxide
dimethicone
water
ethylene glycol monoethyl ether
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
soya lecithin
butyl alcohol
alcohol
aluminum oxide

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide